For DEA-registered pharmaceutical manufacturers, distributors, hospitals, and pharmacies, the challenge of complying with the Drug Enforcement Administration’s (DEA) myriad of federal regulations is a primary concern.
At QPharma®, our DEA Compliance practice provides compliance consulting and program development designed to mitigate risk and diversion of controlled substances in accordance with DEA and State Board of Pharmacy regulations. Our experienced team is led by a former DEA Diversion Investigator who has worked in every area of the pharmaceutical supply chain, from manufacturing and distribution, to pharmacy and physician consultation. He and his team provide expert guidance to clients around the development of Suspicious Order Monitoring (SOM) programs, controlled substance procedures, quota calculation, pharmacy operations, and more. We are committed to giving our clients the guidance necessary to maintain full compliance with the complex regulations enforced by DEA and other regulatory authorities.
End-To-End Compliance Consulting Solutions
- DEA “Mock” Audits
- Suspicious Order Monitoring Program Review
- Due Diligence/Diversion Analysis
- DEA Compliance Training
- SOP Reviews
- Pharmacy Reviews
- Physician Risk Analysis
- Retainer Services
To learn more about QPharma’s DEA compliance expertise, please contact us.